We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
AusPAR: Cetuximab
Australian Public Assessment Report
Device/Product Name
Erbitux
Active ingredients
Cetuximab
AusPAR Date
Published
Sponsor
Submission Number
PM-2012-00340-3-4
Submission Type
Major variation (review of indications, changes to Product Information)
Decision
Approved